PQ 392
392. Deputy Bernard J. Durkan asked the Minister for Health the extent to which ongoing testing of new and orphan drugs continues; the number of cases approved in each of the past 12 months to date; the extent to which availability of such drugs can be enhanced by way of specific changes or accelerated process; the extent to which remuneration continues to play an important role in making such drugs available to suitable patients; and if he will make a statement on the matter. [55461/21]
Introduced
11 November 2021
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
11 November 2021
Summary
392. Deputy Bernard J. Durkan asked the Minister for Health the extent to which ongoing testing of new and orphan drugs continues; the number of cases approved in each of the past 12 months to date; the extent to which availability of such drugs can be enhanced by way of specific changes or accelerated process; the extent to which remuneration continues to play an important role in making such drugs available to suitable patients; and if he will make a statement on the matter. [55461/21]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 11 November 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2021-11-11/392/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2021-11-11/pq_392